Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
We discuss results of ORIGIN, a multicenter parallel groups study for efficiency assessment of insulin glargin against polyunsaturatedomega-3 fatty acids or placebo regarding cardiovascular and/or mortality risk reduction in patients with impaired fasting glycemia,impaired glucose tolerance or type...
Saved in:
| Main Authors: | Elena Valer'evna Biryukova, Alexander Sergeevich Ametov, Mikhail Borisovich Antsiferov, Alsu Gafurovna Zalevskaya, Galina Afanas'evna Mel'nichenko, Ashot Musaelovich Mkrtumyan, Marina Vladimirovna Shestakova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2012-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/6092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-12-01) -
On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01) -
Osobennosti sakharnogo diabeta v pozhilom vozraste i printsipy terapii
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2005-12-01) -
Ispol'zovanie inkretinov v lecheniisakharnogo diabeta 2 tipa - vcherashnyaya mechta,blizkaya k real'nosti segodnya
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2006-06-01) -
Individualisation of basal insulin therapy of type 2 diabetes: evidence from large randomized controlled trials
by: S. V. Nedogoda, et al.
Published: (2023-01-01)